Bullish Case: Harmony's confidence in its flagship product WAKIX and its strategic acquisition of Zynerba to diversify their treatment portfolio can potentially drive long-term growth[PR News Wire][Helium].


Show historical bullish cases

Bearish Case: The acquisition deal involves a significant upfront payment of $60M, and uncertainty of up to $140M in contingent rights, posing potential financial stress [Helium][Market Watch].


Show historical bearish cases

Takeaway: Harmony's strategy to diversify and bolster its portfolio through the Zynerba acquisition holds potential for growth but comes with financial risks and uncertainties about product effectiveness [Helium][Helium][Helium].


Show historical takeaways

Potential Outcomes:

1. Acquisition diversifies Harmony’s portfolio and increases market share, benefiting the company's future revenues (60% chance) [beststocks.com][Helium].

2. Zygel fails in treating Fragile X syndrome, leading to financial loss for Harmony (20% chance) [pharmtech.com][Helium].

3. Regulatory, legal, or financial hurdles delay Acquisition completion beyond expected year (20% chance) [Helium].


September 14, 2023



Correlated Stock Forecasts

Assets that tend to move strongly with HRMY



BLUE Forecast + Options Trading Strategies   [BLUE]  Bluebird bio (0.87)


BNTX Forecast + Options Trading Strategies   [BNTX]  BioNTech SE (0.81)


PFE Forecast + Options Trading Strategies   [PFE]  Pfizer (0.79)


NDAQ Forecast + Options Trading Strategies   [NDAQ]  Nasdaq (0.78)


VLY Forecast + Options Trading Strategies   [VLY]  Valley National Bancorp (0.78)



Uncorrelated Stock Forecasts

Assets with little price relationship to HRMY



CRSP Forecast + Options Trading Strategies   [CRSP]  CRISPR Therapeutics (0.01)


AFRM Forecast + Options Trading Strategies   [AFRM]  Affirm (-0.01)


VCLT Forecast + Options Trading Strategies   [VCLT]  Vanguard Long-Term Corporate Bond (-0.01)


TMO Forecast + Options Trading Strategies   [TMO]  Thermo Fisher Scientific (-0.01)


ZS Forecast + Options Trading Strategies   [ZS]  Zscaler (-0.02)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against HRMY



RACE Forecast + Options Trading Strategies   [RACE]  Ferrari (-0.78)


SNY Forecast + Options Trading Strategies   [SNY]  Sanofi (-0.79)


INOD Forecast + Options Trading Strategies   [INOD]  Innodata (-0.81)


ONON Forecast + Options Trading Strategies   [ONON]  On (-0.82)


RIOT Forecast + Options Trading Strategies   [RIOT]  Riot Blockchain (-0.84)